13 drug(s) with this reaction
12,499 total reports
Asthenia has been reported as an adverse reaction across 13 drug(s) manufactured by Amgen Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 12,499 adverse event reports mention asthenia in connection with Amgen Inc products.
This page provides a breakdown of which Amgen Inc drugs are most commonly associated with asthenia, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Amgen Inc drugs have asthenia listed in their FDA adverse event reports, sorted by report count:
In addition to asthenia, the following adverse reactions have been reported across Amgen Inc's drug portfolio:
13 drug(s) manufactured by Amgen Inc have asthenia listed in their FDA adverse event reports: DENOSUMAB, APREMILAST, PEGFILGRASTIM, DARBEPOETIN ALFA, ERENUMAB-AOOE, and others.
There are a combined 12,499 reports of asthenia across 13 Amgen Inc drug(s) in the FDA adverse event database.